Three solid Aim stocks to buy now
Many Aim-listed stocks if held for two years, are exempt from inheritance tax. Here, professional investor James Rae picks three Aim stocks to buy now.
Each week, aprofessional investor tells us where he'd put his money. This week: James Rae ofCharles Stanley.
Having paid taxes all your life you could be forgiven for wanting to save your children from a large tax bill when you pass away. One method of avoiding inheritance tax (IHT) is through investing in shares quoted on the Aim, the London Stock Exchange's junior market, many of which qualify for business relief. If these shares are held for two years and are still held at the date of death, then they can be exempt from IHT. Avoiding IHT in this way means you keep access to your capital and doesn't involve you in the legalcomplexities or cost of many other IHT-avoidance schemes.
The Aim market is often associated with failing startup companies and volatile resource stocks, but this is to ignore the quality of many Aim companies, which are highly cash-generative businesses that are market leaders in their respective niches. In addition, many of these companies have a high degree of management ownership (often the founders of the business), which creates a solid platform for strong performance.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Many investors are concerned about the state of the UK economy and are looking for themes that may provide some relative resilience. The pet market is relatively immune to economic pressure as owners increasingly treat pets as an additional child. One way to play this theme is through CVS Group (Aim: CVSG); the leading provider of veterinary services in the UK. It has strong cash flow, which it uses to acquire additional veterinary surgeries across the country. As the group grows, its competitive advantage increases as economies of scale lower the prices they pay for drugs and other supplies. In addition, the group benefits from referring work internally to its laboratories and pet crematoriums. The stock is relatively expensive, but it looks set for continued growth in the UK and through expansion into the Netherlands.
Restore (Aim: RST) is the largest UK-owned document-management business, caring for more than 14 million boxes in secure buildings nationwide. Despite the growth of cloud services, the need for physical storage remains and Restore continues to grow its business organically and through acquisition. Annual storage fees create recurring revenues and expansion in its shredding, scanning and office-relocation businesses will provide cross-selling opportunities.
Renew Holdings (Aim: RNWH) is a highly specialised engineering-services business with excellent revenue visibility. The company has healthy margins, strong cash generation and a growing order book. Crucially, the vast majority of its revenues arise from necessary maintenance operations. These include helping to decommission the Sellafield nuclear site and maintaining tunnels and embankments for Network Rail. The shares feel too cheap on a price/earnings ratio of 14 times, considering the order book strength and potential for growth through acquisitions.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
James Rae is a portfolio manager at Charles Stanley
-
Google shares bounce on Gemini 2.0 launch
Google has launched the latest version of its Gemini AI platform, and markets have responded positively. Is it time to buy Google shares?
By Dan McEvoy Published
-
Millions of pension savers could get targeted support under new proposals
The proposals are part of the FCA’s attempt to tackle the advice gap, after 75% of savers admitted they don’t have a clear plan for their pension
By Katie Williams Published
-
Somero: trading this overlooked bargain
Features Mechanical-screed maker Somero dominates its niche and is attractively valued. Matthew Partridge picks the best way to trade it.
By Dr Matthew Partridge Published
-
How to find big profits in small companies
Cover Story The small- and micro-cap sectors are risky and volatile. But with careful research and patience, investors could make huge gains. Matthew Partridge explains how to find the market’s top tiddlers.
By Dr Matthew Partridge Published
-
The hidden gems on Aim, London's junior market
Features Aim, London’s junior market, is risky – but you can find solid stocks at low prices. Scott Longley reports.
By Scott Longley Published
-
Is Aim finally coming of age?
Features The Aim market of mostly smaller companies has traditionally been seen as a bit of a backwater. Is it time to change that view? Matthew Partridge talks to Paul Latham and Richard Power of fund management company Octopus.
By Dr Matthew Partridge Published
-
Three Aim-listed firms that will thrive in a post-Brexit world
Opinion Matt Tonge and Victoria Stevens of the Liontrust UK Smaller Companies Fund pick three Aim-listed firms that will survive Brexit turmoil.
By moneyweek Published
-
Fetch! The Chinese small-cap stocks to buy in the Year of the Dog
Opinion Each week, a professional investor tells us where she’d put her money. This week: Tiffany Hsiao of Matthews Asia selects three Chinese small-cap stocks with exciting potential.
By Tiffany Hsio Published
-
Small and mid-cap stocks with big potential
Opinion Professional investor Guy Anderson of the Mercantile Investment Trust selects three small and medium-sized firms with promising prospects that the market has missed.
By Guy Anderson Published
-
Get cheap, reliable growth from smaller companies
Features One of the most reliable long-term investment trends is the long-term outperformance of smaller companies over blue chips. Max King picks some of the best ways to buy into this growth.
By Max King Published